8-K 1 v121180_8k.txt ================================================================================ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ------------ FORM 8-K ------------ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2008 VNUS Medical Technologies, Inc. (Exact name of registrant as specified in its charter) Delaware 000-50988 94-3216535 ---------------------------- ------------------------ ------------------------ (State or other jurisdiction (Commission File Number) (I.R.S. Employer of incorporation) Identification Number) 5799 Fontanoso Way San Jose, California 95138 (408) 360-7200 (Address of principal executive offices including zip code and registrant's telephone number, including area code) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): [ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) [ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) [ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) [ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) =============================================================================== Item 2.02 Results of Operations and Financial Condition. On July 29, 2008, VNUS Medical Technologies, Inc. (the "Company") issued a press release announcing its financial results for the second quarter of 2008. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 of this Current Report on Form 8-K and the information contained in the press release referenced herein shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this Item 2.02 of this Current Report on Form 8-K and the press release referenced herein is not incorporated by reference into any filings of VNUS, whether made before or after the date of this Current Report on Form 8-K, regardless of any general incorporation language in the filing, unless explicitly incorporated by specific reference into such filing. Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description ------- ---------------------------------------------------------------------- 99.1 Press Release of VNUS Medical Technologies, Inc., dated July 29, 2008 entitled "VNUS Medical Technologies Reports Second-Quarter 2008 Results" SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: July 29, 2008 VNUS MEDICAL TECHNOLOGIES, INC. By: /s/ Peter Osborne ----------------------------------------- Name: Peter Osborne Title: Chief Financial Officer and Vice President of Finance & Administration INDEX TO EXHIBITS FILED WITH THE CURRENT REPORT ON FORM 8-K DATED JULY 29, 2008 Exhibit Description -------- ------------------------------------------------------------------ 99.1 Press Release of VNUS Medical Technologies, Inc., dated July 29, 2008 entitled, "VNUS Medical Technologies Reports Second-Quarter 2008 Results"